magnolol has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CH; Chen, JH; Chung, JG; Hsu, FT; Tsai, JJ | 1 |
Chen, JH; Hsu, FT; Kuan, LY; Su, CM; Weng, YS | 1 |
2 other study(ies) available for magnolol and Disease Exacerbation
Article | Year |
---|---|
Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Topics: Animals; Apoptosis; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; Liver Neoplasms, Experimental; Medicine, Chinese Traditional; NF-kappa B; Signal Transduction; Transcription Factor RelA | 2020 |
Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Disease Progression; Humans; Lignans; Male; Mice, Inbred BALB C; Mitochondria; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Kinase C-delta; Protein Kinase Inhibitors; Receptors, Death Domain; Signal Transduction | 2020 |